How are Pharmakogenetik Medicheck and Langlebigkeit related?

Pharmacogenetics (Medicheck) analyzes genetic variants affecting drug metabolism (e.g., CYP2D6, CYP2C19). Optimized medication selection can reduce adverse effects and improve adherence – both factors that may promote long-term health and thus indirectly influence life expectancy. However, the direct link between individual pharmacogenetic SNPs and overall lifespan is weakly supported. Longevity is multifactorial: genetics, diet, exercise, environment, and healthcare all play major roles. The Medicheck provides useful guidance for personalized drug therapy, but not a lifespan prediction. Evidence for extending lifespan via pharmacogenetics is limited (mixed). Marketing often overpromises relative to the science. Responsible use means discussing results with a physician and not misinterpreting them as an anti-aging miracle.